CRBP - Corbus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRBP is currently covered by 4 analysts with an average price target of $252.46. This is a potential upside of $243.19 (2623.41%) from yesterday's end of day stock price of $9.27.

Corbus Pharmaceuticals's activity chart (see below) currently has 13 price targets and 34 ratings on display. The stock rating distribution of CRBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 18.51% with an average time for these price targets to be met of 43.9 days.

Highest price target for CRBP is $75, Lowest price target is $28, average price target is $45.75.

Most recent stock forecast was given by KALPIT PATEL from B. RILEY on 30-Jul-2025. First documented stock forecast 14-Nov-2016.

Currently out of the existing stock ratings of CRBP, 22 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$28

$18.73 (202.05%)

$40

3 days ago
(30-Jul-2025)

0/3 (0%)

$18.74 (202.38%)

Buy

$58

$48.73 (525.67%)

$82

2 months 26 days ago
(07-May-2025)

1/7 (14.29%)

$51.87 (846.17%)

154

Buy

$75

$65.73 (709.06%)

5 months 15 days ago
(18-Feb-2025)

2/6 (33.33%)

$66.79 (813.52%)

7

Buy

$22

$-13 (-37.14%)

$22

1 years 11 months 24 days ago
(09-Aug-2023)

2/2 (100%)

$15.85 (257.72%)

216

Hold

$53.7

$44.43 (479.29%)

$36.6

4 years 4 months 18 days ago
(15-Mar-2021)

3/8 (37.5%)

$-14.4 (-21.15%)

62

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?

On average it took 43.9 days on average for the stock forecasts to be realized with a an average price target met ratio 18.51

Which analyst has the current highest performing score on CRBP (Corbus Pharmaceuticals) with a proven track record?

JAMES EDWARDES JONES

Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones works at RBC and has 13 price targets and 9 ratings on CRBP

Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?

Christopher Marai with highest potential upside - $953.26

Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones with lowest potential downside - -$13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?